NCI Clinical Trials Get a Boost from Public-Private Partnership

What happens when you blend two artificial intelligence (AI) tools with a deep collection of clinical data and well-established research practices—a partnership that works!

This unique collaboration between NCI and Lunit (a company that develops AI-powered solutions for cancer diagnostics and therapeutics) will give researchers from both sides of this public-private partnership the opportunity to make greater inroads into personalized treatment for patients with cancer.

Michael Pollack, Ph.D., Supervisory Technology Transfer Manager in NCI’s Technology Transfer Center, notes, “Our partnership with Lunit is an excellent example of how NCI is working to improve innovation through collaboration. Our team is continuously searching for new and more efficient ways of conducting research at NCI. In this case, NCI is able to apply cutting-edge, AI-guided approaches to our clinical trial data. The first project will involve analyzing pathology images from CCR’s Center for Immuno-Oncology’s clinical studies.”

Read the full story. 

Excerpted from NCI Center for Biomedical Informatics & Information Technology News